Integral Derivatives’s Exelon EXC Stock Holding History

Integral Derivatives’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-38,275	Closed	-$1.03M	–	1177
2017 Q3	$1.03M	Buy	38,275 +20,470	+115%	+$548K	0.02%	489
2017 Q2	$458K	Buy	+17,805	New	+$453K	0.01%	726
2017 Q1	–	Sell	-20,469	Closed	-$518K	–	1225
2016 Q4	$518K	Sell	20,469 -10,235	-33%	-$243K	0.01%	714
2016 Q3	$729K	Buy	30,704 +13,039	+74%	+$328K	0.02%	515
2016 Q2	$458K	Buy	+17,665	New	+$437K	0.01%	626
2015 Q2	–	Sell	-70,100	Closed	-$1.68M	–	1145
2015 Q1	$1.68M	Sell	70,100 -16,824	-19%	-$417K	0.04%	336
2014 Q4	$2.3M	Sell	86,924 -22,011	-20%	-$565K	0.04%	389
2014 Q3	$2.65M	Buy	108,935 +59,164	+119%	+$1.39M	0.05%	367
2014 Q2	$1.29M	Buy	49,771 +36,172	+266%	+$922K	0.02%	588
2014 Q1	$326K	Buy	+13,599	New	+$286K	0.01%	1015

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Integral Derivatives's EXC Position: Q2 2017 in Review

Integral Derivatives sold out of Exelon (EXC) in Q2 2017, closing a stake of 7,846 shares — an estimated $200K sold.

Integral Derivatives first reported a position in EXC in Q4 2013 and held it in 6 quarters. The position peaked at $1.4M in Q4 2013. 793 funds tracked by Wall St. Rank hold EXC as of Q2 2017.

Integral Derivatives reported no remaining Exelon position as of Q2 2017 after selling out during the quarter.
Integral Derivatives sold 7,846 Exelon shares in Q2 2017, an estimated $200K.
Integral Derivatives first reported a position in Exelon in Q4 2013 and held it in 6 quarters.
Integral Derivatives's Exelon position peaked at $1.4M in Q4 2013.
793 funds tracked by Wall St. Rank held Exelon as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.